Curaleaf Germany

Curaleaf has a fully integrated medical cannabis business with licensed cultivation in several nations, including Germany, with adjoining domestic manufacturing. Curaleaf supplies medical cannabis on a wholesale basis across Germany for the medical-use market.

On September 19, Curaleaf’s domestic buildout in Deutschland took another step forward by completing its agreement to acquire a 55% stake in Four 20 Pharma GmbH, a fully EU-GMP & GDP licensed German producer and distributor of medical cannabis. Four 20 Pharma is among the largest cannabis operators in Germany, with a greater than 10% share in the medical market.